EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

2950 reported adverse events

Drug classes: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]

These side effects are most commonly reported by patients taking EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE:

# Side effect Count
0 NAUSEA 213
1 BLOOD GLUCOSE INCREASED 192
2 VOMITING 189
3 DIARRHOEA 158
4 DIABETIC KETOACIDOSIS 156
5 WEIGHT DECREASED 144
6 FATIGUE 131
7 KETOACIDOSIS 124
8 DRUG INEFFECTIVE 117
9 DIZZINESS 109
See all common reactions for EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SYNOVIAL DISORDER 25 0.0549
1 ALLERGIC SINUSITIS 25 0.0291
2 EUGLYCAEMIC DIABETIC KETOACIDOSIS 81 0.0196
3 KETOACIDOSIS 124 0.0166
4 VITAMIN B12 DECREASED 25 0.0087
5 ANTINUCLEAR ANTIBODY POSITIVE 25 0.0077
6 DIABETIC KETOACIDOSIS 156 0.0065
7 BLOOD URIC ACID INCREASED 25 0.0043
8 JOINT EFFUSION 26 0.0038
9 IMPAIRED GASTRIC EMPTYING 38 0.0028
See all enriched reactions for EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE